IR415 T11669
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
IR415 selectively interacts with HBx (Kd=2 nM) and blocks HBV-mediated RNAi suppression, reverses the inhibitory effect of HBx protein on the activity of the dicer endoribonuclease. HBV: hepatitis B virus; HBx: hepatitis B virus X protein. IR415 is a pote
CAS nr:
452967-14-5
Purity:
98%
Molecular Weight:
296,34
SMILES:
S=C(NCCCN1C=CN=C1)NC2=CC=C(F)C=C2F
Formula:
C13H14F2N4S
Pathway:
Microbiology/Virology
Target:
HBV
